4//SEC Filing
Buchanan Lucas W. 4
Accession 0001593968-23-000180
CIK 0001397702other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 8:01 PM ET
Size
21.8 KB
Accession
0001593968-23-000180
Insider Transaction Report
Form 4
Buchanan Lucas W.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-17$1.60/sh+45,000$72,000→ 236,527 total - Sale
Common Stock
2023-01-17$54.68/sh−45,000$2,460,623→ 191,527 total - Exercise/Conversion
Common Stock
2023-01-19$20.00/sh+25,762$515,240→ 217,289 total - Sale
Common Stock
2023-01-19$53.40/sh−25,762$1,375,755→ 191,527 total - Sale
Common Stock
2023-01-19$53.40/sh−2,716$145,041→ 188,811 total - Exercise/Conversion
Option (right to buy)
2023-01-19−12,766→ 7,643 totalExercise: $1.60From: 2015-12-03Exp: 2025-12-03→ Common Stock (12,766 underlying) - Exercise/Conversion
Option (right to buy)
2023-01-19−25,762→ 7,331 totalExercise: $20.00From: 2019-05-03Exp: 2029-04-03→ Common Stock (25,762 underlying) - Exercise/Conversion
Common Stock
2023-01-19$1.60/sh+12,766$20,426→ 204,293 total - Sale
Common Stock
2023-01-19$53.40/sh−12,766$681,736→ 191,527 total - Exercise/Conversion
Option (right to buy)
2023-01-17−45,000→ 20,409 totalExercise: $1.60From: 2015-12-03Exp: 2025-12-03→ Common Stock (45,000 underlying)
Holdings
- 13,518(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
- [F2]This transaction was executed in multiple trades at price ranging from $53.79 to $57.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at price ranging from $52.68 to $54.71. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on December 13, 2022.
- [F5]These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
- [F6]All of the shares subject to this option are fully vested and exercisable as of the date hereof.
- [F7]One forty-eighth of the shares subject to the option shall vest on May 3, 2019 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001769830
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 8:01 PM ET
- Size
- 21.8 KB